MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by RISKMANAGEMENTon Nov 19, 2007 12:11pm

235 Views

Post# 13830121

NEWS_________________________________________

MedMira 6.85 million shares for debt 2007-08-24 16:26 ET - Shares for Debt The TSX Venture Exchange has accepted for filing the company's proposal to issue 6.85 million shares to settle outstanding debt for $685,000. Number of creditors: Three Insider Amount Deemed price creditor owing per share Shares Mannaland Trust $600,000 10 cents Six million The company shall issue a news release when the shares are issued and the debt extinguished.

Bullboard Posts

Morning Market Outlook for Oct. 2, 2024